Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.13 USD | -4.05% | +2.68% | -1.15% |
Evolution of the average Target Price on INmune Bio, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering INmune Bio, Inc.
Baird | |
B. Riley | |
BTIG |
EPS Revisions
- Stock Market
- Equities
- INMB Stock
- Consensus INmune Bio, Inc.